APT(SH:688617) Sou Hu Cai Jing·2025-07-12 23:12Core Points - The stock price of Huatai Medical (688617) increased by 1.22% to 295.0 CNY as of July 11, 2025, with a market capitalization of 41.599 billion CNY, ranking 4th in the medical device sector [1] - The company held its 23rd meeting of the second board of directors on July 7, 2025, where several key resolutions were passed, including changes to registered capital and amendments to the company's articles of association [1][5] - Huatai Medical plans to distribute a cash dividend of 17.50 CNY per 10 shares and to increase capital by 4.5 shares for every 10 shares held, resulting in a total share count increase to 141,013,796 shares [1][5] Company Announcements - The company announced the abandonment of part of its preemptive rights and plans to increase capital by 50 million CNY in its subsidiary, Yiweidi, which focuses on non-vascular interventional business [2][5] - The board approved adjustments to the 2021 restricted stock incentive plan, including changes to grant prices and quantities due to management's request to defer stock vesting [3][5] - The adjustments include a reduction in the grant price for A-class restricted stock from 137.68 CNY to 93.74 CNY and for B-class restricted stock from 123.56 CNY to 84.01 CNY [3]